Journals / Turkish Journal of Anaesthesiology and Reanimation / 2022 / Cilt: 50 - Sayı: 1

Acute Kidney Injury in Intensive Care Unit Patients with Coronavirus Disease 2019

Pages
S1–S7
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, predisposing factors should be determined and effective treatment strategies should be established in the early period.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The incidence of acute kidney injury during the hospital stay in patients with coronavirus disease 2019 varies between 8% and 17% in studies.
📊
Key Findings & Data:This rate is at the highest levels among the critical patient group monitored in the intensive care unit (23% [14-35%]).
💡
Conclusion & Impact:Therefore, predisposing factors should be determined and effective treatment strategies should be established in the early period.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: The incidence of acute kidney injury during the hospital stay in patients with coronavirus disease 2019 varies between 8% and 17% in studies. This rate is at the highest levels among the critical patient group monitored in the intensive care unit (23% [14-35%]). In this study, we aimed to assess the incidence of acute kidney injury development, effective factors, and clinical outcomes of patients monitored in the intensive care unit due to coronavirus disease 2019. Methods: A total of 801 patients were analyzed. Patients were divided into 2 groups as those developing acute kidney injury (n = 408) and those not developing acute kidney injury (n = 393). Patients developing acute kidney injury were staged according to the Kidney Disease Improving Global Outcomes criteria. Results: In all patients, the mortality rate was 65.2%. The mortality rate for those developing acute kidney injury was identified to be high by a statistically significant degree compared to those not developing acute kidney injury. The mortality rate in Kidney Disease Improving Global Outcomes criteria stage 1 was 81.3%, in stage 2 was 88.3%, and in stage 3 was 91.5%. The frequency of diabetes mellitus type 2, coronary artery disease, and chronic obstructive pulmonary disease in the group developing acute kidney injury was found to be statistically significantly higher. We have found positive correlations between acute kidney injury development and age, sex, history of diabetes mellitus, and ferritin levels in the multivariate analysis. Conclusions: The development of acute kidney injury in intensive care unit patients with coronavirus disease 2019 is associated with increased mortality. Therefore, predisposing factors should be determined and effective treatment strategies should be established in the early period.

🔖

Cite This Article

BIÇAK, E. A., BIÇAK, M., SALIK, F., KAÇAR, C. K., UZUNDERE, O., KAYA, S., AKELMA, H. (2022). Acute Kidney Injury in Intensive Care Unit Patients with Coronavirus Disease 2019. Turkish Journal of Anaesthesiology and Reanimation, Cilt: 50 - Sayı: 1, S1–S7. https://ajindex.com/articles/418138

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. McMichael TM, Currie DW, Clark S, et al. Epidemiology of COVID-19 in a long-term care facility in King County, Washington. N Engl J Med. 2020
  2. 382(21):2005-2011. [CrossRef] 2. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020
  3. 382(18):1708- 1720. [CrossRef] 3. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020
  4. 395(10223):507-513. [CrossRef] 4. Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L. Acute kidney injury in critically ill patients with COVID- 19. Intensive Care Med. 2020
  5. 46(7):1339-1348. [CrossRef] 5. White-Dzuro G, Gibson LE, Zazzeron L, et al. Multisystem effects of COVID-19: a concise review for practitioners. Postgrad Med. 2021
  6. 133(1):20-27. [CrossRef] 6. Monteil V, Kwon H, Prado P, and et al. Inhibition of SARSCoV- 2 infections in engineered human tissues using clinicalgrade soluble human ACE2. Cell. 2020
  7. 181(4):905-913.e7. [CrossRef] 7. Gheblawi M, Wang K, Viveiros A, et al. Angio tensi n-con verti ng Enzyme 2: SARS-CoV-2 receptor and regulator of the reninangiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020
  8. 126(10):1456-1474. [CrossRef] 8. Diao B, Wang C, Wang R, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nat Commun. 2021
  9. 12(1):2506. [CrossRef] 9. Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020
  10. 97(5):829-838. [CrossRef] 10. Gameiro J, Fonseca JA, Oliveira J, et al. Acute Kidney Injury in Hospitalized Patients with COVID-19
  11. [CrossRef] 11. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury – fingerprint — Experts@Minnesota. Available at: https://ex perts.umn. edu/e n/pub licat ions/ kidne y-dis ease- impro ving- globa l-out comes -kdig o-acu te-ki dney- injur /fing erpri nts/. Accessed November 26, 2020. 12. Gagliardi I, Patella G, Michael A, Serra R, Provenzano M, Andreucci M. COVID-19 and the kidney: from epidemiology to clinical practice. J Clin Med. 2020
  12. 9(8):2506. [CrossRef] 13. Hua W, Xiaofeng L, Zhenqiang B, Jun R, Ban W, Liming L. Consideration on the strategies during epidemic stage changing from emergency response to continuous prevention and control. Chinese J Endem.